Try our Advanced Search for more refined results
May 15, 2014
In re: Nexium Antitrust
Case Number:
14-1521
Court:
Nature of Suit:
Companies
- AstraZeneca PLC
- Burlington Stores Inc.
- Dr. Reddy's Laboratories Ltd.
- Giant Eagle Inc.
- International Brotherhood of Electrical Workers
- Ranbaxy
- Rite Aid Corp.
- Rochester Drug Cooperative Inc.
- Supervalu Inc.
- Teva Pharmaceutical Industries Ltd.
- United Food & Commercial Workers International Union
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
January 23, 2015
Nexium Ruling Offers Road Map For Pay-For-Delay Classes
The First Circuit's decision to uphold class certification in the Nexium pay-for-delay litigation despite the presence of some uninjured members in the group may be a hollow victory for the heartburn-drug purchasers after their recent loss at trial, but the ruling offers a boost for other plaintiffs as a bevy of antitrust class actions over pharmaceutical patent settlements forge ahead.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login